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ABSTRACT
Activation-induced cytidine deaminase (AID) protein
initiates Ig gene mutation by deaminating cytosines,
converting them into uracils. Excision of AID-induced
uracils by uracil-N-glycosylase is responsible for
most transversion mutations at G:C base pairs. On
the other hand, processing of AID-induced G:U
mismatches by mismatch repair factors is respon-
sible for most mutation at Ig A:T base pairs. Why
mismatch processing should be error prone is
unknown. One theory proposes that long patch
excision in G1-phase leads to dUTP-incorporation
opposite adenines as a result of the higher
G1-phase ratio of nuclear dUTP to dTTP.
Subsequent base excision at the A:U base pairs
produced could then create non-instructional tem-
plates leading to permanent mutations at A:T base
pairs (1). This compelling theory has remained
untested. We have developed a method to rapidly
modify DNA repair pathways in mutating mouse
Bc e l l sin vivo by transducing Ig knock-in splenic
mouse B cells with GFP-tagged retroviruses, then
adoptively transferring GFP
+cells, along with appro-
priate antigen, into primed congenic hosts. We have
used this method to show that dUTP-incorporation is
unlikely to be the cause of AID-induced mutation of
A:T base pairs, and instead propose that A:T muta-
tions might arise as an indirect consequence of nu-
cleotide paucity during AID-induced DNA repair.
INTRODUCTION
Somatic hypermutation (SHM) of antibody (Ig) genes in
antigen-activated germinal centre B cells optimizes the
antibody repertoire to maintain effective immunity (2).
SHM is initiated by deamination of cytosine (C) bases in
Ig V genes by activation-induced cytidine deaminase
(AID), which produces mismatched uracil:guanine (U:G)
base pairs [reviewed in (3)]. If left unprocessed, U:G base
pairs are inherited as a thymine:adenine (T:A) base pair
(i.e. a C:G to T:A transition mutation) in one daughter
cell following replication (4), but excision of AID-induced
uracils by uracil N-glycosylase (UNG) creates a
non-instructional template on one strand. Such templates
can induce bypass by low ﬁdelity translesion DNA poly-
merases, potentially converting the founder C base into
any other base in one daughter cell [i.e. producing
transversion or transition mutations at C:G base pairs
(5)]. Alternatively, processing of founder U:G mismatches
by the mismatch repair heterodimer MutSa (or, to a minor
extent, by UNG) introduces mutations at nearby A:T base
pairs via recruitment of the translesion DNA polymerase
(pol) Z (6). Non-homologous end-joining factors are also
recruited in response to AID-induced DNA damage, both
to mediate class switch recombination and to inhibit hom-
ologous recombination or translocation (7–10), but there
is no evidence for their direct involvement in generating
point mutations (11).
How mismatch processing of AID-induced U:G base
pairs occurs and why repair occurs with low ﬁdelity is
unknown. While it is clear that mutation of Ig A:T base
pairs is largely dependent on MutSa (MSH2 plus MSH6
proteins), the role of MutLa in SHM is more controversial
[reviewed in (3)], even though this factor is vital for ‘clas-
sical’ post-replication mismatch repair [reviewed in (12)].
In addition, the mechanism that recruits pol Z during
repair of AID-induced U:G mismatches is unknown.
The MutSa sub-unit MSH2 can bind and activate pol Z
(13). However, much of the MSH2-mediated repair of
non-Ig genes targeted by AID as ‘bystander genes’ is
error-free (14), implying that MSH2 is not obliged to
recruit pol Z when processing AID-induced U:G
mismatches. Furthermore, translesion polymerases may
usually be activated by mono-ubiquitinated PCNA to
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such as abasic sites (15). AID-induced A:T mutation
involves PCNA mono-ubiquitination (16), but mismatch
processing of U:G base pairs would not be expected to
produce a non-instructional template. Neuberger et al.
(1) proposed that incorporation of dUTP, in place of
dTTP, during processing of mismatches in cell-cycle
phase G1 might explain why pol Z is recruited during
SHM. Nuclear dUTP levels are presumed to be elevated
during G1-phase as a result of reduced accumulation of
mRNA coding for nuclear dUTPase (17–19), implying
that any unscheduled DNA synthesis that occurs in
G1-phase cells will involve some incorporation of dUTP
in place of dTTP opposite adenine bases. Processing of
AID-induced U:G mismatches by MutSa in G1-phase
could therefore generate U:A base pairs during excision
patch re-synthesis. Subsequent base excision at U:A base
pairs would then create abasic sites opposite A (rather
than G) requiring the recruitment of a translesion DNA
polymerase—i.e. pol Z—for replication (1) (Figure 1). The
‘dUTP-incorporation’ hypothesis potentially explains why
mismatch repair of AID-induced U:G mismatches appears
to introduce mutations almost exclusively at A:T base
pairs, because it proposes preferential use of pol Z to
bypass abasic sites generated at A:T base pairs (Figure 1).
The dUTP-incorporation hypothesis infers that the
maintenance of nuclear dUTPase activity throughout the
cell cycle should suppress AID-induced mutation of A:T
base pairs. Because models of AID-induced A:T mutation
can currently be tested in vivo only, we developed a system
to perform rapid transgenesis of B cells hypermutating
in vivo and used it to show that constitutive expression
of mouse or EBV dUTPase in the nucleus of mutating B
cells does not reduce mutation of A:T base pairs.
Surprisingly, constitutive expression of mouse dUTPase
signiﬁcantly increased mutation at A:T base pairs, by a
mechanism that appeared to involve the MSH2 protein.
We propose that error-prone pol Z may be recruited to Ig
genes because AID induces Ig mismatch repair when
nuclear dNTP levels are inadequate to support processive




 /  mice (20,21) were bred on
C57BL/6J backgrounds under speciﬁc pathogen free con-
ditions in the animal care facility of the Centenary
Institute. Msh2
 /  mice (22) were back-crossed >10
times onto C57BL/6J mice and crossed with
SWHELrag1
 /  mice to produce msh2
 / SWHELrag1
 / 
mice. C57BL/6J host mice were purchased from Animal
Resources Centre (Canning Vale, Western Australia). All
mice were used in accordance with approvals issued by the
University of Sydney Animal Ethics Committee.
Reagents
PCR ampliﬁcations for making constructs used Phusion
DNA polymerase (Finnzymes, Finland). Other enzymes
used to digest and ligate DNA were purchased from
New England Biolabs (Ipswich, MA, USA).
Recombinant EBV dUTPase was puriﬁed as described
earlier (23). Culture supernatants containing soluble
mouse CD40L were produced by transiently transfecting
HEK293 cells (using Lipofectamine 2000, Invitrogen,
Carlsbad, CA, USA) with a plasmid that expresses
truncated mouse CD40L fused to the FLAG-epitope
(24). All other chemicals, oligonucleotides or puriﬁed
proteins were purchased from Sigma-Aldrich (Sydney,
Australia), unless otherwise stated.
DNA constructs
Human DUT-N cDNA was ampliﬁed from Ramos cells
(ATCC number CRL-1923) using oligonucleotide primers
439 (GCC GGA TCC GGC CGC CAT GCC CTG CTC
TGA AGA GAC—restriction site used for cloning
underlined) and 440 (TTG CTC GAG CTA TTA ATT
CTT TCC AGT GGA ACC AAA ACC). Mouse DUT-N
cDNA was ampliﬁed from A20 cells (ATCC number
TIB-208) using primers 469 (TCC GAA TTC GCC
GCC ATG CCC TGC TCG GAA GAT GCCG) and
477 (TCC GTC GAC TAA TTC TTC CCG GTG GAG
CCG AAGC, including the stop codon) or 468 (CCA
GGG CCC CAT TCT TCC CGG TGG AGC CGA
AGC, deleting the stop codon). An EBV dUTPase
sequence was ampliﬁed from Raji (ATCC number
CCL-86) genomic DNA using primers 466 (CCA GGT
ACC ACC ATG GAG GCC TGT CCA CAC ATAC)
and 472 (GTT TAC GTA CGC GTT ATC ATT GAC
CCG AGG ATC CAA ACCC, including the stop codon)
or 467 (GGA GGG CCC CTT GAC CCG AGG ATC
CAA ACC CC, deleting the stop codon). The bacterio-
phage PSB-2 ugi sequence was sub-cloned from a plasmid
obtained from Javier Di Noia [MRC-LMB, Cambridge,
UK (5)]. vDUT3X sequences were created by
PCR-mediated site-directed mutagenesis using primers
492 and 493 (CCG ACA ATC TTT GGC GCC GCG
GGC CTG GCC and GGC CAG GCC CGC GGC
Figure 1. The deoxyuridylate-incorporation model for AID-induced
mutation of A:T base pairs as proposed by Neuberger et al. (1).
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mutations (underlined), and primers 494 and 495 (CAT
GTT GGC ATC ATC AAT CCC GGC TAC ACG
GGG and CCC CGT GTA GCC GGG ATT GAT
GAT GCC AAC ATG) to create a D76N mutation
(underlined). Coding sequences with stop codons were
directly cloned into the pMIG vector (25) for
co-expression with GFP via an internal ribosome entry
site (IRES), or cloned minus the stop codon into vector
pEGFP-N1 (Clontech) to fuse with the N-terminal me-
thionine of EGFP via the vector-encoded linker peptide
‘GARDPPVAT’. DUT-GFP fusion sequences were then
sub-cloned into the pMIG vector to replace the IRES and
GFP sequences (Figure 3A). The sequences of all con-
structs assembled using PCR were checked by automated
ﬂuorescent sequencing (AGRF, Brisbane).
Nuclear protein extraction and western blotting
Transduced GFP
+ NIH/3T3 or A20 cells (1–10 10
6)
were resuspended in 0.4ml ice-cold buffer A [10mM
HEPES, pH 7.9, 10mM KCl, 0.1mM EDTA, 0.1mM
EGTA, 1mM DTT, 100mg/ml AEBSF, 1mg/ml
Aprotinin and 1mg/ml Pepstatin (Roche Diagnostics)].
Following incubation on ice for 15min to swell the cells,
25ml of ice-cold 10% (v/v) NP-40 was added and the cells
were pipetted brieﬂy to disrupt plasma membranes. The
lysed cell samples were centrifuged at 12000g at 4 C for
30s. Pelleted nuclei were resuspended in 100ml of ice-cold
buffer B (20mM HEPES, pH 7.9, 0.4M NaCl, 1mM
EDTA, 1mM EGTA, 1mM DTT, 100mg/ml AEBSF,
1mg/ml Aprotinin and 1mg/ml Pepstatin), pipetted for
2min, and incubated on ice for 30min with occasional
pipetting. Samples were centrifuged at 12000g for 5min
at 4 C and the supernatant (the ‘nuclear protein’ fraction)
was transferred to new tubes. All samples were stored at
 70 C. Approximately 20mg aliquots of protein were
electrophoresed on 4–12% NuPAGE Bis–Tris (+MES
buffer) polyacrylamide gels (Invitrogen) and transferred
to PVDF membranes using an iBlot apparatus
(Invitrogen). PVDF membranes blocked with 5% (w/v)
skim milk powder dissolved in 10mM Tris–HCl, pH 7.4,
0.9% (w/v) NaCl and 0.1% (v/v) Tween-20 (TBST) were
incubated overnight at 4 C with rabbit anti-GFP anti-
serum (Abcam, Cambridge, UK) or rabbit anti-human
nuclear dUTPase (Imgenex, San Diego, CA, USA)
diluted in TBST containing 5% (w/v) BSA. Washed mem-
branes were then incubated with goat anti-rabbit IgG1
conjugated to horse radish peroxidase (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) for 1h at room
temperature. Bound antibodies were revealed on washed
and blotted membranes by incubation with Immobilon
chemiluminescent HRP substrate (Millipore) and lumines-
cence was recorded with a Kodak Image Station 4000MM
Digital Imaging System (Kodak, NY, USA).
Retroviral transduction and adoptive transfer
Near-conﬂuent Phoenix-Eco cells (75cm
2, Orbigen, San
Diego) were transiently transfected using Lipofectamine
2000 (Invitrogen) with 15mg pMIG plasmid. Following
culture for 48h at 32 C in B cell medium [IMDM
supplemented with 2mM L-glutamine, 0.1mM
non-essential amino acids, 10mM HEPES (pH 7.4),
100mg/ml streptomycin, 100U/ml penicillin, and
5 10
 5M 2-mercaptoethanol], culture supernatants
were ﬁltered and stored at  70 C. Fresh SWHELrag1
 / 
splenocytes were separated from red blood cells using
Histopaque 1083, then activated at 37 C in six-well
plates at a density of 10
6 cells/ml with soluble recombinant
CD40L-FLAG fusion protein and anti-FLAG antibody
(4mg/ml clone M2) for 1day in B cell medium.
Splenocytes were ‘spinoculated’ (1100g, 45min, 20 C)
with 2 -diluted retrovirus supernatants in the presence
of 8mg/ml Polybrene, washed, then incubated for a
further 2 days in activating medium. A second
spinoculation was performed the day after the ﬁrst
spinoculation, if necessary. GFP
+ cells (usually 5–30%
of live cells) were puriﬁed using a FACS-Vantage DIVA
cell sorter (BD Biosciences). Sorted cells were mixed with
HEL-SRBC [prepared as described earlier (26)] and
injected via a tail vein into 8- to 12-week-old hosts
which had been primed i.p. with 10
8 SRBC 5–7 days
earlier. Each host received 1 10




8 HEL-SRBC in a bolus of 0.25–0.5ml B cell
medium.
Cell-cycle analysis
Transduced cells were incubated at 10
7 cells/ml in
complete medium plus 10mg/ml Hoechst 33342 at 37 C
for 30min. Washed cells were resuspended in complete
medium and kept ice-cold for FACS analysis.
Collection of mutation data
Six or seven days after adoptive transfer, single viable
GFP
+, HEL-binding cells were FACS-sorted, using
single cell mask settings, into individual wells of 96-well
PCR plates (4titude, UK) containing 15ml/well of ice-cold
Mg-free 1  Taq DNA polymerase buffer (Promega
‘Go-Taq’ buffer) supplemented to include 0.1mM
EDTA, 1% Tween-20 detergent and 0.25mg/ml protein-
ase K (Roche Diagnostics). Zero cells were sorted into
three or more non-adjacent wells to provide negative
controls. Plates were sealed, snap frozen and stored at
 70 C. Thawed plates were brieﬂy centrifuged, incubated
at 56 C for 40min to digest protein, then at 95 C for 8min
to inactivate proteinase k. Ampliﬁcation of the single
HyHEL10 VDJH gene rearrangement present in each
well was performed by nested PCR as follows. Digested
cells were diluted to a volume of 25ml consisting of 1 
PCR buffer, 2mM MgCl2, 0.2mM dNTP, 0.5U recom-
binant Taq DNA polymerase (Invitrogen), and 1.0pmol
each of primers 85 (GTT GTA GCC TAA AAG ATG
ATG GTG) and 503 (CTT TTG CAG GCT CCA CCA
GACC). Primary PCR then consisted of 20 cycles of 95 C
for 15s, 55 C for 1min and 72 C for 1min to produce a
1.07kb product. Secondary PCR reactions (27.5ml vol)
used 2.5ml primary PCR aliquots as templates, 10pmol
each of primers 452 (TTG AAG CTT AAA AGA TGA
TGG TGT TAA GTC) and 502 (CAG AAT TCT GAG
ACC GAG GCT AGA TGCC) and consisted of 40 cycles
of 95 C for 15s, 60 C for 30s and 72 C for 1min to give a
8122 Nucleic Acids Research, 2010,Vol.38, No. 221.02-kb product. DNA from successful ampliﬁcations
(generally 65–80% of wells) was treated with exonuclease
I and alkaline phosphatase (27), then 523bp of sequence
was determined by Macrogen Inc (Seoul, Korea) or the
Australian Genome Research Facility (Brisbane,
Australia) using primer 453 (CAA GGA TCC CAA
CTT CTC TCA GCC GGC).
Analysis of mutations
All mutations were manually conﬁrmed using Sequencher
software (Gene Codes Corp.). No mutation was counted if
two or more bases were detected at one position, to
exclude bases incorporated erroneously by Taq DNA
polymerase during PCR. Sequences were sorted according
to the phylogenetic tree generated for each mouse using
MacVector software (MacVector, Inc.). Custom Excel
spreadsheets (Microsoft Corporation) automatically
collated mutations. Prism software (GraphPad Software
Inc.) was used for all statistical analyses. Fisher’s exact
tests were used to detect signiﬁcant variation in the G:C
to A:T mutation ratio, as shown in Table 1.
Non-parametric (Kruskal–Wallis) ANOVA, including
Dunn’s multiple comparison tests, was used to identify
signiﬁcant changes in mutation frequencies shown in
Figure 5.
Measurement of dUTPase function
Nuclear extracts from transduced NIH/3T3 cells were
incubated with rabbit anti-GFP antiserum (0.6ml per
44cm
2 cell culture) in buffer B for 0.5h on ice, then
incubated with paramagnetic Dynabeads conjugated to
goat anti-rabbit IgG (Invitrogen) for 1h at 4 C. Washed
beads were resuspended in buffer B and samples subjected
to semi-quantitative anti-GFP western blotting, using
serially-diluted recombinant GFP (a gift from Kimberley
Vincent and Mikka Jormakka, Centenary Institute) as a
standard. Bead concentrations were then adjusted to nor-
malize GFP concentrations. Normalized bead aliquots
were incubated for 1h with 100pmol dUTP or dTTP at
37 Ci n2 0ml buffer NEB2 (New England Biolabs). dUTP
or dTTP remaining after incubation was measured using a
modiﬁed primer extension assay (28). Brieﬂy, primer
oligonucleotide 379 (biotin-TGG GAG AAG TTA
GGA CTC ACC TGC) and template oligonucleotide
482 (50-TTT ATT TAT TTA TTT ATT TAG CAG
GTG AGT CCT AAC TTC TCC CA-30) were annealed,
then 3.2pmol aliquots incubated in triplicate reactions in
96-well PCR plates at 42 C for 45min with 0.5 units
exonuclease-free Klenow DNA polymerase fragment,
29pmol
3H- dATP (GE Healthcare) and 1.6ml
extract-treated dUTP or dTTP (equivalent to 8pmol
dUTP or dTTP prior to dephosphorylation), in a 50ml
reaction containing 1  buffer NEB2 and 0.1mg/ml
BSA. Reactions to generate standard curves were identi-
cal, but used dUTP or dTTP standards (0–10pmol).
Completed reactions were quantitatively transferred to
96-well streptavidin-coated ScintiPlates (Perkin Elmer)
and incubated for an additional 30min at room tempera-
ture to allow streptavidin-mediated recruitment of
incorporated
3H into proximity with the solid phase scin-
tillant. Tritium incorporation was determined by scintilla-
tion counting in a Perkin Elmer ‘Wallac Microbeta Trilux’
model 1450 liquid scintillation counter.
RESULTS
Rationale: retroviral gene expression in adoptive germinal
centre B cells
To test the dUTP-incorporation hyypothesis, we aimed to
express dUTPase throughout the cell cycle in germinal
centre B cells. To this end, we exploited an Ig
double-transgenic (SWHEL) mouse line ﬁrst described by
Table 1. Summary of mutations detected in adoptive SWHEL B cells recovered after adoptive transfer





b Freq (%) mutated
a
G C A:T G:C A:T
Mice Seqs Mut’d Seqs Mutations Ts Tv Ts Tv A T Ts Tv
1 ires GFP SWHEL 5 125 77 165 39 17 32 6 58 13 1.3 0.19 0.32 0.11
2 ugi ires GFP SWHEL 1 67 36 83 28 0 19 0 29 7 1.3 ns 0.00 0.35 0.12
3 mDUT ires GFP SWHEL 3 117 88 304 46 25 38 12 129 54 0.9 * 0.25 0.73 0.39
4 vDUT ires GFP or vDUT-GFP SWHEL 6 191 92 187 38 13 29 6 85 16 0.9 * 0.00 0.39 0.11
5 vDUT-3X ires GFP SWHEL 2 99 56 117 15 8 16 6 49 23 0.6 ** 0.13 0.45 0.26
6 ires GFP msh2
 /  SWHEL 3 152 80 141 38 18 74 4 6 1 19.1 0.15 0.00 0.00
7 mDUT ires GFP msh2
 /  SWHEL 3 144 80 172 48 22 95 4 2 1 56.3 ns 0.02 0.40 0.14
8 vDUT ires GFP msh2
 /  SWHEL 3 192 79 147 56 10 69 2 7 3 13.7 ns 0.00 0.00 0.00
9 vDUT-3X ires GFP msh2
 /  SWHEL 2 137 57 108 35 6 61 3 1 2 36.0 ns 0.00 0.00 0.00
10 PCR error control
c SWHEL – 1 8 8 2 2 1010 00
11 No prime control
d SWHEL 26 3 6 9 2 0 3 0 3 1
Data were pooled from the number of mice indicated.
aFrequency of G:C or A:T base pairs that have undergone mutation, expressed as a percentage.
bP-values from contingency tables (Fisher’s exact test) for numbers of mutations at G:C and A:T base pairs, compared to cells of the same genotype
transduced with the control ires-GFP construct. **P<0.01; *P<0.05; ns, not signiﬁcant.
cMutations detected in sequences ampliﬁed from single SWHEL B220-CD4+ (i.e. non-B cell) blood cells.
dMutations detected in transduced cells 7 days after adoptive transfer into a host that had not been primed with SRBC previously.
Ts: transition mutation, Tv: transversion mutation.
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embryonic stem cell in which the VDJH-rearrangement
from the HyHEL10 hybridoma was targeted to the IgH
locus. SWHEL mice also carry the HyHEL10 VJ -re-
arrangement as a randomly-integrated low copy number
transgene. Together, the IgH and Igk transgenes confer
speciﬁcity for the antigen hen egg lysozyme (HEL) upon
 5–10% of the B cells present in the circulation. The elim-
ination of receptor editing capacity by crossing into a
RAG-deﬁcient background confers HEL-speciﬁcity on
100% of SWHELrag1
 /  B cells (21). A tk-neo cassette
was present upstream of the transgenic VDJH exon in
the original SWHEL mouse strain (20). Because this
cassette may interfere with SHM of the nearby VDJH-
region (data not shown), it was deleted by cre-mediated
recombination to produce the SWHEL
[Dtk-neo] sub-line
used here (26). For simplicities sake, we shall refer to the
SWHEL
[Dtk-neo] sub-line as SWHEL in this report. When
adoptively transferred into congenic hosts immunized
with HEL conjugated to sheep red blood cells
(HEL-SRBC), SWHEL B cells proliferate, form germinal
centres, class-switch and undergo extensive SHM (26).
We activated SWHELrag1
 /  splenocytes in vitro with
recombinant CD40L (Tnfsf5 or CD154), then
retrovirally-transduced activated cells with pMIG
vectors (25) (Figure 2A–B). The frequency of transduced
(i.e. GFP
+) cells ranged between 1 and 30%, implying that
nearly all GFP
+cells carried only one retroviral integrant.
Transductions were carried out over 3 days of culture
prior to adoptive transfer, to allow double transduction
to be performed if required. After 3 days culture, GFP
+
cells were puriﬁed by FACS and 10
4 transduced cells
transferred to congenic hosts, along with HEL-SRBC as
antigen, by tail vein injection (Figure 2B and C).
Transduced cells proliferated in adoptive hosts
(Figure 2D), but only if those hosts had been primed
with SRBC at least 5 days earlier (Supplementary Figure
S1). Proliferation was antigen speciﬁc, because cells
adoptively transferred with mock-conjugated SRBC,
instead of HEL-conjugated SRBC, did not proliferate,
even in primed hosts (Supplementary Figure S1). Several
days after adoptive transfer, transduced SWHEL B cells
(i.e. HEL-binding, GFP
+ cells) were FACS-sorted from
host spleens at one cell per well into 96-well PCR plates
(Figure 2D). Nested PCR ampliﬁcation of the single
HyHEL10 VDJH-allele present in each well, followed by
direct automated sequencing of PCR products (Figure 2E
and F), showed that transduced cells underwent mutation
quantitatively comparable to ‘typical’ SHM [‘typical’
SHM is summarized in (3)]. That is, mutation frequencies
were A > G > C >> T (referring to the non-template
strand, Table 1, row 1); G:C transitions were favoured
over G:C transversions, especially when C was in the
non-coding strand (Table 1, row 1); and hotspots
occurred at WRC motifs (data not shown).
During single-cell PCR, Taq DNA polymerase can in-
corporate incorrect bases. If this happens early in the
PCR reaction, it results in a detectable ‘heteroduplex’
mutation: a site where more than one base is detected in
a single read. As long as heteroduplex mutations were
justiﬁably ignored, the contribution of PCR error to mu-
tations scored was negligible (Table 1, row 10).
Furthermore, mutation prior to transduction was also
negligible, because transduced cells transferred to
non-primed hosts accumulated very few mutations







Figure 2. Procedure for transduction/adoptive transfer. Genes of interest were cloned into pMIG retroviral vectors (A), which were used to trans-
duce SWHELrag1
 /  splenocytes activated with rCD40L (B). Transduced (GFP
+) cells were sorted and injected into the tail veins of primed hosts,
along with a bolus of HEL-SRBC antigen (C). Several days later, transduced (GFP
+HEL-binding) cells were sorted from the spleens of hosts into
PCR plates at 1cell/well (D). DNA from lysed cells was template for nested PCRs using primers speciﬁc for the SWHEL VDJ gene (E). Products from
successful PCRs were directly sequenced to collate mutations (F).
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was veriﬁed using the uracil glycosylase inhibitor protein
(ugi) from bacteriophage. In accordance with seminal
work with ung
 /  mice and ugi-transfected DT40 cells
(5,29), retroviral expression of ugi protein signiﬁcantly
suppressed transversion mutation at G:C base pairs in
adoptive SWHEL cells, while having little effect on
mutation at A:T base pairs (Table 1 row 2).
Testing the dUTP-incorporation hypothesis
The dUTP-incorporation hypothesis requires the presence
of a pool of dUTP in the nucleus of cells undergoing
AID-induced mismatch repair (1). To reduce this pool,
we cloned mouse and human nuclear dUTPase cDNAs
(herein called mDUT or hDUT, respectively) into pMIG
retroviral vectors (25). Constructs were engineered to
express nuclear dUTPase as either a polypeptide fused
to the N-terminus of GFP or as a polypeptide distinct
from GFP via an internal ribosome entry site (IRES)
(Figure 3A). Because viral proteins are less likely to be
subject to post-translational mechanisms which might
regulate mouse or human dUTPase activity, we also
cloned the EBV dUTPase gene (herein called vDUT)
from the EBV-infected Raji cell line (Supplementary
Figure S2).
Mouse A20 B cells and NIH/3T3 ﬁbroblasts were
transduced to express GFP±hDUT, mDUT or vDUT.
Western blotting of asynchronous cells (i.e. representing
all cell-cycle phases) conﬁrmed ectopic DUT expression in
transduced cells and also conﬁrmed that GFP was detect-
able only as a fusion protein when cells were transduced
with DUT-GFP fusion constructs (Figure 3B). hDUT ex-
pressed poorly in the mouse cells and was not used in
further experiments. Green ﬂuorescence was highly
concentrated in the nucleus of the majority of NIH/3T3
cells transduced to express mDUT-GFP or vDUT-GFP
fusion proteins, whereas green ﬂuorescence was much
more disseminated in cells transduced to express GFP
alone (Figure 3C). Accumulation of DUT-GFP fusion
proteins appeared to be  150% higher in S/G2
compared to G1 phase cells (Figure 3D), but this
probably reﬂects the larger size of cells with  2n DNA
content (Supplementary Figure S3A). mDUT and vDUT
migrated as single antibody-reactive bands (Figure 3B).
Thus, we found no evidence for differential accumulation
or obvious post-translational modiﬁcation of mDUT or
vDUT during the cell cycle, although phosphorylation of
Ser11 in hDUT or mDUT does not cause a detectable
change in SDS–PAGE mobility (36).
To assess the catalytic activity of DUT constructs,
DUT-GFP fusion proteins were enriched from nuclear
extracts of transduced NIH/3T3 cells using anti-GFP
coupled to magnetic beads, then the ability of bead-bound
DUT-GFP fusion proteins to degrade dUTP or dTTP was
assessed (‘Materials and Methods’ section). Both
vDUT-GFP and mDUT-GFP fusion proteins degraded
dUTP in preference to dTTP (Figure 4). To conﬁrm that
we were detecting genuine dUTPase activity, we made a
vDUT mutant: vDUT3X constructs expressed vDUT
protein in which three amino acids known to interact
Figure 3. Expression of recombinant DUT proteins in transduced cells.
(A) Retroviral constructs used to express DUT as fusion proteins with
GFP, or co-translated with GFP via an IRES. (B) Blots of nuclear
proteins from transduced mouse A20 B cells (lanes 1–6) or transduced
NIH/3T3 cells (lanes 7–9), probed with (top) anti-hDUT antibody
cross-reactive with mDUT but not vDUT, or (bottom) anti-GFP
antibodies. Black arrows indicate DUT proteins, white arrows
indicate GFP, and black/white arrows indicate DUT-GFP fusion
proteins. Predicted molecular masses of polypeptides—ignoring
post-translational modiﬁcations—are: GFP, 27kDa; hDUT, 18kDa;
vDUT, 31kDa; mDUT, 17kDa; mDUT-GFP, 45kDa; vDUT-GFP,
59kDa; vDUT3X-GFP, 59kDa. (C) Localization of green ﬂuorescence
in NIH/3T3 cells stably transduced to express GFP or DUT-GFP
fusion proteins. Images i–iii are from confocal microscopy, while
image iv is from conventional light microscopy. (D) Histograms
generated from FACS analysis of NIH/3T3 cultures transduced to
express (left) mDUT-GFP fusion protein, or (right) vDUT-GFP
fusion protein, The histograms depict the following: (Top) DNA
content of (grey histograms) GFP
+ cells, or (hollow black histograms)
non-transduced GFP
-ve cells from the same cultures. (Bottom) GFP
ﬂuorescence in GFP
+ cells with (grey histograms) >2n DNA content,
or (hollow black histograms)  2n DNA content.
Nucleic Acids Research, 2010,Vol.38, No. 22 8125with substrate—Asp76, Arg171 and Ser172 [see (23)]—
were changed to Asn, Ala and Ala, respectively
(Supplementary Figure S2). The 3X mutations did not
appear to substantially affect protein folding because ac-
cumulation of vDUT3X-GFP fusion protein in the
nucleus was indistinguishable from accumulation of
vDUT-GFP fusion protein (Figure 3). As expected,
vDUT3X-GFP fusion protein possessed no detectable
dUTPase activity (Figure 4). We also FACS-puriﬁed
cells expressing vDUT-GFP in G1- or S/G2-phases
(Supplementary Figure S3). Semi-quantitative blotting
conﬁrmed that slightly more vDUT-GFP was extractable
from S/G2-phase nuclei, but the dUTPase activity of
G1-phase vDUT-GFP and S/G2-phase vDUT-GFP were
very similar (Figure 4E).
Constitutive dUTPase expression does not reduce
mutation at A:T base pairs
Expression of vDUT in activated B cells invivo appeared
to be somewhat cytotoxic and/or anti-proliferative
because vDUT-transduced cells were more difﬁcult to
recover after 7 days in adoptive hosts than cells
transduced with GFP or mDUT plus GFP (data not
shown), and their level of mutation was lower than
control cells (Table 1). Among other explanations,
vDUT expression may have induced selection for cells
that had undergone less proliferation invivo. The ability
of vDUT to activate toll-like receptors (30) might be
related to this observation. Because SHM depends on pro-
liferation, and also because we were interested in relative
mutation of G:C versus A:T base pairs, statistical analyses
in Table 1 and Figure 5 exclude irrelevant non-mutated
cells. Surprisingly, ectopic expression of mDUT or vDUT
in adoptive SWHEL B cells increased mutation of A:T base
pairs relative to G:C base pairs (Table 1), a ﬁnding incon-
sistent with the dUTP-incorporation hypothesis. The in-
ability of ectopic DUT expression to eliminate A:T
mutation was independent of selection for HEL-binding,
because abundant A:T mutation was evident in both exon
and intron sequences from cells expressing ectopic DUT
(Figure 6). Surprisingly, ectopic expression of mutant
vDUT3X protein also increased A:T mutation relative
to G:C mutation, in a manner very similar to expression
of ‘wild-type’ vDUT (Table 1). Like wild-type vDUT,
vDUT3X-expression also reduced the recovery of
transduced cells from hosts (data not shown) and
reduced the overall frequency of mutation similarly to
wild-type vDUT (Table 1). This suggests that the affect
of vDUT on cell survival or proliferation and mutation
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Figure 4. Relative activities of bead-bound dUTPase-GFP fusion
proteins extracted from transduced NIH/3T3 cells. (A) Annealed oligo-
nucleotides 379 and 482 used for primer extension assays (28). Black
text indicates primers, while grey text indicates nucleotides that can be
incorporated by primer extension. ‘Asterisk’ indicates
3H-dATP. (B)
Standard curves used to convert
3H-incoporation into pmoles dUTP
(black squares) or dTTP (black triangles) available for primer exten-
sion. dUTP or dTTP standards (100pmol) were exposed (white
symbols), or mock-exposed (black symbols) to 37.5ng puriﬁed vDUT
(23) at 37 C for 2h, prior to serial dilution and use in primer extension
reactions. (C and D) Histograms indicate mean percentage±SEM of
100pmol of (C) dUTP, or (D) dTTP degraded in a 60min
pre-incubation with normalized limiting quantities of bead-bound
fusion protein, prior to primer extension. (E) Mean
percentage±SEM of 100pmol of dUTP degraded by bead-bound
protein equivalent to 2.5 10
5 G1- or S/G2-phase 3T3 cells or 3T3
cells transduced to express mDUT-GFP (details in Supplementary
Figure S3).
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(30)]. This does not necessarily imply that the effect of
ectopic mDUT on mutation was also independent of its
dUTPase activity, because mDUT and vDUT are struc-
turally unrelated proteins (23). We did not experiment
with an mDUT mutant because, unlike vDUT, mamma-
lian dUTPase holoenzyme is trimeric (31). Since dUTPase
is an essential protein in yeast (32), incorporation of
mutant mDUT into endogenous trimers had potential to
produce an uninterpretable phenotype.
The minor UNG-mediated pathway of A:T mutation is
also not ablated by ectopic dUTPase
Although ectopic DUT expression did not reduce A:T
mutation in ‘wild-type’ SWHEL B cells, it remained
possible that MSH2-independent A:T mutation might be
sensitive to ectopic DUT expression. We therefore
transduced msh2
 / SWHEL B cells to express GFP,
vDUT and GFP, mDUT and GFP or vDUT3X and
GFP. vDUT-expression in msh2
 /  cells appeared to be
particularly cytotoxic or anti-proliferative, because very
few GFP
+ cells were recoverable from hosts 7 days after
adoptive transfer (data not shown). We therefore analysed
mutation in transduced msh2
 / SWHEL B cells after only
6 days in adoptive hosts. Adoptive SWHEL cells appeared
to rely on MSH2 protein for A:T mutation substantially
more than reported for Peyer’s patch B cells [reviewed in
(1)]. This meant that only seven mutations at A:T were
detected in 80 mutated sequences from GFP-transduced
msh2
 / SWHEL B cells (Table 1). Transduction of
msh2
 / SWHEL B cells with mDUT, vDUT or vDUT3X
had no signiﬁcant effect on A:T mutation in msh2
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Figure 5. Histograms showing the mean number of point mutations (±SEM) at G:C or A:T base pairs per mutated SWHEL IgH sequence recovered
by single cell PCR from GFP
+ cells, 6 or 7 days after adoptive transfer. The sequence window is illustrated by Figure 6. The number of sequences
contributing to each mean is indicated by the number, n. Cells were transduced to express GFP plus the protein indicated. Control cells expressed
GFP alone. Transitions (‘ts’, dark grey) and transversions (‘tv’, light grey) at G:C base pairs are shown as stacked histograms:—note that the mean
no. of G:C transversions in cells transduced with ugi was zero (Table 1). All mutations (i.e. transitions and transversions) at A:T base pairs are
indicated by the white histograms. White asterisks are placed on histograms where the mean was signiﬁcantly different (P<0.05) from the control
mean by non-parametric ANOVA.
A
B
Figure 6. The distribution of mutations at G:C and A:T base pairs across SWHEL alleles from MSH2-proﬁcient B cells. (A) Mirrored mutation
proﬁles for (top) cells expressing ugi plus GFP, or GFP alone, versus (bottom) cells expressing vDUT-GFP fusion protein, vDUT plus GFP or
mDUT plus GFP. Histograms represent the number of mutations detected at a particular (black) G:C base pair or (white) A:T base pair. The black/
white ‘bar code’ at bottom shows the distribution of G:C and A:T base pairs in the sequenced region of the germline SWHEL IgH allele, counting
from the start ATG codon as nucleotide 1–3. The scale diagram below the skylines indicates the positions of coding (shaded) and non-coding (thin
line) regions, including CDRs [IMGT deﬁnition (41)]. Arrows indicate 50 primers used for nested PCR ampliﬁcation and the 30 primer used for
sequencing (the 30-PCR primers are off-scale). The location of a 562-bp germline deletion characteristic of the SWHEL allele (20) is shown by ‘’.
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ectopic dUTPase does inﬂuence UNG-mediated A:T
mutation, but we were unable to detect that inﬂuence
because our experiments lacked sufﬁcient statistical
power.
DISCUSSION
Advantages of the transduction/adoptive transfer model
and single-cell PCR
The established technique to detect perturbation of
Ig SHM in DNA repair-defective mice is sequencing
of endogenous IgH genes ampliﬁed from activated
Peyer’s patch B cells of middle-aged transgenic or
gene-targeted mice (33). Our new transduction/adoptive
transfer method bypasses the need to make germline-
or bone marrow-transgenic mice, and transduced
adoptive B cells acquire mutations in an otherwise
wild-type milieu. Furthermore, our methodology
replaces cloning of bulk PCR products with single-cell
PCR, and thus avoids multiple artefacts which arise
from PCR ampliﬁcation of DNA from pooled cells.
That is, every mutation can be assigned with certainty to
an individual cell when single cell PCR is used, and
the mutations present in each cell are never erroneously
counted twice. Similar precision is impossible when
conventional pooled DNA ampliﬁcation is used (1,34).
For instance, ampliﬁcation of J-CH intron DNA from
bulk DNA of F1 mice results in cross-over between
IgH SNPs in many of the sequences recovered by
cloning, but no such cross-over is detected when
single cell PCR is used [(33); K.K.E.Lau and C.J.Jolly,
unpublished data]. Inheritance of common mutations by
clonally-related daughter cells can affect data collected by
single cell PCR, as it does data collected by any other
method, but because many founder cells contribute to
the mutating pool in our system (we transfer  10
4
HEL-reactive cells), co-occurrence of two or more muta-
tions in cells from the same host [a working deﬁnition of
‘clonality’ (35)] represented a mere 6/856 mutations
(0.7%) in our msh2
+/+ mutation database (these mutations
are highlighted in Supplementary Figure S4).
MSH2-deﬁcency greatly increased the accumulation of
mutations at hotspots, causing more cells to share muta-
tions, as noted before (35). However, the same
hotspots occurred repeatedly in independent experiments,
proving that the increased hotspot focus arose from pref-
erential targeting and not from clonal expansion
(Supplementary Figure S4). We did not prune our data-
bases of ‘clonal’ mutations, which inevitably over-
compensates for clonality (35), because our msh2
+/+
database demonstrated that clonality was a minor issue
in our experimental system. Selection must affect the mu-
tations that are tolerated in the SWHEL IgH exons, but
antigen selection would have been uniform in all of our
experiments. Furthermore, we showed that ectopic
dUTPase did not suppress A:T mutation in exon or
intron sequences (Figure 6).
Negation of the ‘dUTP-incorporation’ model of
AID-induced A:T mutation
We used our transduction/adoptive transfer model to test
the intriguing hypothesis that incorporation of dUTP
opposite adenine bases during G1-phase long patch
excision repair is the mechanism by which AID induces
mutation of A:T base pairs in Ig V genes (1). Ectopic ex-
pression of active mouse and viral dUTPase in the nucleus
of G1-phase cells did not signiﬁcantly reduce mutation at
A:T base pairs in Ig V genes invivo. Although we cannot
be certain that G1-phase expression of nuclear dUTPase
reduces G1-phase nuclear dUTP levels, it is probable that
it does for the following reasons. vDUT-GFP extracted
from G1-phase cells was active (Figure 4E), and it is
unlikely that a non-covalent inhibitor of dUTPase could
suppress both mDUT and vDUT function, because the
structure and surface epitopes of these two enzymes are
quite dissimilar (23). Finally, in natural infections EBV
expresses vDUT most highly in non-dividing (i.e.
G1-phase) cells (37), where vDUT presumably functions
to degrade dUTP in the nucleus. We therefore conclude
that dUTP-incorporation is unlikely to be involved in the
mechanism of AID-induced mutation of A:T base pairs
induced by AID via either mismatch repair or UNG,
lending credence to the notion that AID-induced A:T
mutation is directly due to the low ﬁdelity of pol Z (6).
An alternative model for recruitment of pol g to
mutating antibody genes
Although both vDUT and mDUT caused signiﬁcant
changes in Ig mutation frequencies, they did not cause
the same changes, and the changes induced did not neces-
sarily depend on dUTPase activity, so the mechanism is
unknown. It is possible that the changes we observed are
due to statistical error. Nonetheless, it is worthwhile to
consider what the observed changes might indicate.
Ectopic mDUT increased mutation at A:T base pairs in
msh2
+/+ cells, but not in msh2
 /  cells (Figure 5), suggest-
ing that it induced an MSH2-dependent A:T mutation
process, as does AID. Since endogenous mDUT is
abundant in S-phase cells (17–19), it seems likely that
ectopic mDUT exerts its effects on antibody mutation
outside S-phase. If this is so, our data are consistent
with Neuberger et al.’s (1) proposal that MSH2 processes
U:G base pairs in antibody genes outside S-phase, even
though our data do not support a role for
dUTP-incorporation in producing mutations. Why
though, should a translesion polymerase such as pol Z
be recruited to synthesize DNA in an excision patch
induced by a U:G mismatch? Both U or G provide in-
structional templates for DNA pol d, the polymerase re-
cruited by classical post-replication mismatch repair (12).
We propose a novel possibility—stalling of DNA synthe-
sis as a consequence of inappropriate nucleotide pools
during G1-phase mismatch repair. Direct measurement
of dNTP concentrations in (inherently leaky) nuclei of
germinal centre B cells is not feasible, because it requires
cold fractionation of organelles from very large numbers
of cells using non-aqueous methods. However, the nuclear
concentrations of dNTPs are 1.8  (dTTP) to 9  (dGTP)
8128 Nucleic Acids Research, 2010,Vol.38, No. 22lower in the nucleus of G1-phase compared to S-phase
CHO cells (38). Low concentrations of substrate dNTPs
during G1-phase AID-induced mismatch repair could
reduce the ﬁdelity of DNA pol Z, inducing further
mismatch repair, and could also explain the recruitment
of DNA pol Z in place of pol d, because pol d could stall in
the presence of sufﬁciently low dNTP concentrations.
Stalling could potentiate mono-ubiquitination of PCNA
and recruitment of error-prone pol Z—an enzyme appar-
ently adapted to function outside S-phase—in place of pol
d (16,39,40).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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